Due to the fact that lung cancer is most often an asymptomatic disease, an important percentage of patients are diagnosed in an advanced stage of the disease when a curative treatment is no longer possible. Studies have shown that identification and determination of specific serum tumor markers might play a key role in order to detect the disease, monitor the response to surgery or chemotherapy and provide an early detection of the recurrences. This is a literature review regarding the role of monitoring pulmonary cancer tumor markers such as NSE, CYFRA 21-1, SCC, CEA, CA 125, ferritin, proGRP, IDH1 or CA 19-9.
Full text sources- ISSN-L: 1584-9244
- ISSN PRINT: 1584-9244
- ISSN ONLINE: 2558-815X
